Furthermore, gain-of-function alterations in the IL-7 signaling pathway were identified in the majority of T-cell lymphomas (reviewed by Waldmann and colleagues) [133]. This evidence concerns the gene IL7 and T-cell non-Hodgkin lymphoma.